InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered micro tissues. Our unique integration of cell & tissue handling automation, tissue phenotyping assays, computational biology (AI), and human organ/tissue data enables rapid identification of safety and efficacy profile of a given treatment for specific patient group cost-effectively before expensive clinical trials. IVS’s technology helps with matchmaking the best treatment for the patient group to expedite the early discovery and clinical trials as well as supporting post-product launch monitoring. To accurately predict efficacy and safety of new drug candidates by recapitulating the human physiology of cardiac, smooth, skeletal muscle, and connective tissues in vitro.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):